BIXT Bioxytran Inc

USD 0.14 0.01 6.415094
Icon

Bioxytran Inc (BIXT) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.141

+0.01 (+6.42)%

USD 0.02B

0.06M

N/A

N/A

Icon

BIXT

Bioxytran Inc (USD)
COMMON STOCK | OTC
USD 0.14
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.02B

N/A

USD 0.14

Bioxytran Inc (BIXT) Stock Forecast

N/A

Based on the Bioxytran Inc stock forecast from 0 analysts, the average analyst target price for Bioxytran Inc is not available over the next 12 months. Bioxytran Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bioxytran Inc is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, Bioxytran Inc’s stock price was USD 0.141. Bioxytran Inc’s stock price has changed by -3.29% over the past week, +22.61% over the past month and -71.22% over the last year.

No recent analyst target price found for Bioxytran Inc
No recent average analyst rating found for Bioxytran Inc

Company Overview Bioxytran Inc

Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglob...Read More

233 Needham Street, Newton, MA, United States, 02464

3

December

USD

USA

Adjusted Closing Price for Bioxytran Inc (BIXT)

Loading...

Unadjusted Closing Price for Bioxytran Inc (BIXT)

Loading...

Share Trading Volume for Bioxytran Inc Shares

Loading...

Compare Performance of Bioxytran Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIXT

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bioxytran Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NONOF
Novo Nordisk A/S +3.76 (+3.07%) USD564.56B 46.25 4.92

ETFs Containing BIXT

Symbol Name BIXT's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Bioxytran Inc (BIXT) Stock

Stock Target Advisor's fundamental analysis for Bioxytran Inc's stock is Bearish.

Unfortunately we do not have enough data on BIXT's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BIXT's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BIXT's stock to indicate if its overvalued.

The last closing price of BIXT's stock was USD 0.14.

The most recent market capitalization for BIXT is USD 0.02B.

Unfortunately we do not have enough analyst data on BIXT's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Bioxytran Inc's stock.

As per our most recent records Bioxytran Inc has 3 Employees.

Bioxytran Inc's registered address is 233 Needham Street, Newton, MA, United States, 02464. You can get more information about it from Bioxytran Inc's website at https://www.bioxytraninc.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...